Meridian Clinical Research has acquired Regional Clinical Research, expanding its North American footprint to more than 20 investigative sites. Meridian now supports more than 60 principal investigators. The acquisition also increases Meridian's existing therapeutic expertise in infectious diseases, neurology, and women's health.
Regional was established in 1993 and operates four research sites in the southern tier of New York. Meridian and Regional are longtime members of Platinum Research Network. The acquisition enhances Meridian's existing therapeutic expertise in infectious diseases, neurology, and women's health.
"This is a perfect addition," said Nicole Osborn, founder and CEO of Meridian. "We've known Regional's leaders and collaborated on best practices for years. Their team shares our mentality and our sense of purpose for patient-centric research."
Meridian is strategically aligned with seven top-10 sponsors and eight top-10 contract research organizations (CROs) - Osborn said the company's acquisition of Regional is a response to client requests to expand relationships. "This strengthens our therapeutic depth in the right areas and gives us room to scale naturally," she said.
"This is a positive step for both companies, our partners, and our clients," said Debra Gabrielson, CEO of Regional and new Vice President at Meridian. "We're aligned with Meridian in many ways and we're eager to leverage its unique resources and programs."
Dr. Bowling and Dr. Elinoff, who shared ownership of Regional, also expressed their satisfaction with the acquisition. "Through almost 30 years we carefully shaped a company that advanced medicine in a uniquely compassionate way. We established a team and legacy we're proud of, and now more than ever, we know Regional is positioned to thrive as part of Meridian."
In addition to three other sites, Regional has also partnered with United Health Services Hospitals since 2002 to conduct outpatient research and has a total of 10 principal investigators. Meridian, which is celebrating its twentieth year in business, now supports more than 60 principal investigators.
"Regional's management team and all of its employees will join the Meridian family, and we look forward to achieving more than ever together," said Osborn.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.